GlassScriptPhysician profile
Tony W Dotson
NPI 1396728499
$2,334.77
in general payments reported to CMS, 2019-2025
30 companies · $505 in 2025
The $505 reported for 2025 was more than what 81% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $235 · 2020: $190 · 2021: $214 · 2022: $313 · 2023: $413 · 2024: $464 · 2025: $505.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,382.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,382.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $396.86 | 2019-2023 | Lo Loestrin Fe |
| Astellas Pharma US INC | $326.12 | 2020-2025 | Veozah, Myrbetriq |
| Shield Therapeutics INC | $226.23 | 2024-2025 | |
| Intuitive Surgical, INC. | $206.92 | 2019-2025 | |
| Sage Therapeutics, LLC | $161.07 | 2024-2025 | Zurzuvae |
| Exeltis, USA INC. | $138.13 | 2021-2025 | Slynd |
| Sumitomo Pharma America, INC. | $108.67 | 2023-2024 | Myfembree |
| Medtronic, INC. | $100.40 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $82.13 | 2023-2025 | |
| Stryker Corporation | $68.84 | 2023 | Stryker |
| Pfizer INC. | $58.49 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $48.19 | 2024 | Gardasil, Gardasil 9 |
| Gynesonics, INC. | $45.12 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Myovant Sciences INC. | $41.53 | 2022 | |
| Therapeuticsmd, INC. | $41.22 | 2019-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $35.14 | 2025 | Ethicon, Stratafix, Vistaseal |
| Amgen INC. | $29.98 | 2023 | Prolia, Evenity |
| Avion Pharmaceuticals | $28.52 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $21.08 | 2021 | |
| Supernus Pharmaceuticals, INC. | $20.16 | 2025 | Qelbree |
| Biohaven Pharmaceutical Holding Company LTD. | $18.78 | 2022 | |
| Axonics, INC. | $17.01 | 2023 | Bulkamid |
| Pacira Pharmaceuticals Incorporated | $16.35 | 2019 | |
| Coopersurgical, INC. | $15.11 | 2023 | Advincula Delineator Uterine Manipulator |
| Viiv Healthcare Company | $14.91 | 2019 | |
| Becton, Dickinson and Company | $14.60 | 2019 | |
| Smith+Nephew, INC. | $14.23 | 2023 | Pico 7 |
| Hologic Sales and Service, LLC | $13.61 | 2022 | |
| Organon LLC | $13.29 | 2024 | |
| Avanos Medical | $12.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tony Dotson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.